Valneva SE (VALN)
6.72
+0.04
(+0.60%)
USD |
NASDAQ |
Sep 10, 15:22
Valneva Enterprise Value : 734.84M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 734.84M |
| September 08, 2026 | 750.96M |
| September 04, 2026 | 754.75M |
| September 03, 2026 | 770.87M |
| September 02, 2026 | 776.56M |
| September 01, 2026 | 724.41M |
| August 31, 2026 | 698.80M |
| August 28, 2026 | 711.13M |
| August 27, 2026 | 723.46M |
| August 26, 2026 | 736.26M |
| August 25, 2026 | 744.32M |
| August 24, 2026 | 741.48M |
| August 21, 2026 | 761.39M |
| August 20, 2026 | 748.11M |
| August 19, 2026 | 750.01M |
| August 18, 2026 | 752.85M |
| August 17, 2026 | 770.87M |
| August 14, 2026 | 777.51M |
| August 13, 2026 | 637.17M |
| August 12, 2026 | 627.69M |
| August 11, 2026 | 631.48M |
| August 10, 2026 | 603.98M |
| August 07, 2026 | 603.98M |
| August 06, 2026 | 592.60M |
| August 05, 2026 | 597.34M |
| Date | Value |
|---|---|
| August 04, 2026 | 588.81M |
| August 03, 2026 | 582.17M |
| July 31, 2026 | 572.69M |
| July 30, 2026 | 583.71M |
| July 29, 2026 | 582.17M |
| July 28, 2026 | 581.22M |
| July 27, 2026 | 571.74M |
| July 24, 2026 | 554.67M |
| July 23, 2026 | 554.67M |
| July 22, 2026 | 566.05M |
| July 21, 2026 | 568.90M |
| July 20, 2026 | 560.36M |
| July 17, 2026 | 575.53M |
| July 16, 2026 | 583.12M |
| July 15, 2026 | 587.39M |
| July 14, 2026 | 585.96M |
| July 13, 2026 | 600.19M |
| July 10, 2026 | 580.28M |
| July 09, 2026 | 603.51M |
| July 08, 2026 | 604.93M |
| July 07, 2026 | 600.19M |
| July 06, 2026 | 613.46M |
| July 02, 2026 | 596.87M |
| July 01, 2026 | 584.07M |
| June 30, 2026 | 597.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pfizer Inc. | 210.12B |
| Nicox SA | -- |
| DBV Technologies SA | 582.52M |
| Cellectis SA | 252.62M |
| Genfit SA | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -36.28M |
| Revenue (Quarterly) | 40.62M |
| Total Expenses (Quarterly) | 76.90M |
| EPS Diluted (Quarterly) | -0.3826 |
| Gross Profit Margin (Quarterly) | 4.58% |
| Profit Margin (Quarterly) | -89.31% |
| Earnings Yield | -31.16% |
| Normalized Earnings Yield | -31.16 |